Basket

  Untick selected:   0
  1. Clinical development programme of peginterferon alfa-2a (40KD) for the treatment of chronic hepatitis. [Basel : Roche], 2004. 20 s.   [1, z toho volných 1]
    book

    book


  This site uses cookies to make them easier to browse. Learn more about how we use cookies.